Original language | English |
---|---|
Article number | 100827 |
Journal | The Lancet Regional Health - Americas |
Volume | 36 |
DOIs |
|
Publication status | Published - Aug 2024 |
Access to Document
Other files and links
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: The Lancet Regional Health - Americas, Vol. 36, 100827, 08.2024.
Research output: Contribution to journal › Comment/debate › peer-review
TY - JOUR
T1 - #VacinaMare campaign
T2 - addressing vaccine inequity in socially vulnerabilised communities
AU - Batista-da-Silva, Amanda A.
AU - Bastos, Leonardo S.L.
AU - Arouca, Luna E.
AU - Gonzaga-da-Silva, Thiago W.
AU - Hamacher, Silvio
AU - Bozza, Fernando A.
AU - Ranzani, Otavio T.
N1 - Funding Information: Declaration of interests : AABS is funded by National Council for Scientific and Technological Development (CNPq), the Coordinating Agency for Advanced Training of Graduate Personnel (CAPES; finance code 001), and the Pontifical Catholic University of Rio de Janeiro. SH is funded by National Council for Scientific and Technological Development (CNPq), and Carlos Chagas Filho Foundation for Research Support of the State of Rio de Janeiro (FAPERJ). The other authors have no conflict of interest to declare. #VacinaMar\u00E9 was a multi-institutional initiative, and funders had no role in the study\u2019s design, the collection, analysis, and interpretation of data, the writing of the manuscript, or the decision to submit the manuscript for publication. Funding Information: The authors thank the Redes da Mar\u00E9 for all their support and the efficient strategies for community engagement and communication during the pandemic. The authors also thank the Presidency of FIOCRUZ for the enthusiastic support in all moments and the Unidade de Apoio ao Diagn\u00F3stico da Covid-19 (UNADIGFIOCRUZ) for supporting the testing diagnosis. The Vacina Mar\u00E9 initiative was funded by Fiocruz and an unrestricted grant from Todos Pela Sa\u00FAde fund. AABS acknowledges funding from CAPES Print (88887.899318/2023-00). OTR acknowledges funding from the END-VOC Project (Horizon 2021\u20132024), funded by the European Union under grant agreement no. 101046314. OTR acknowledges support from the Spanish Ministry of Science and Innovation through the Centro de Excelencia Severo Ochoa 2019\u20132023 programme (CEX2018-000806-S) and from the Generalitat de Catalunya through the Centres de Recerca de Catalunya (CERCA) programme. Funding Information: The authors thank the Redes da Mare for all their support and the efficient strategies for community engagement and communication during the pandemic. The authors also thank the Presidency of FIOCRUZ for the enthusiastic support in all moments and the Unidade de Apoio ao Diagn\u00F3stico da Covid-19 (UNADIGFIOCRUZ) for supporting the testing diagnosis. The Vacina Mar\u00E9 initiative was funded by Fiocruz and an unrestricted grant from Todos Pela Sa\u00FAde fund. AABS acknowledges funding from CAPES Print (88887.899318/2023-00). OTR acknowledges funding from the END-VOC Project (Horizon 2021-2024), funded by the European Union under grant agreement no. 101046314. OTR acknowledges support from the Spanish Ministry of Science and Innovation through the Centro de Excelencia Severo Ochoa 2019-2023 programme (CEX2018-000806-S) and from the Generalitat de Catalunya through the Centres de Recerca de Catalunya (CERCA) programme.
PY - 2024/8
Y1 - 2024/8
UR - http://www.scopus.com/inward/record.url?scp=85196539578&partnerID=8YFLogxK
U2 - 10.1016/j.lana.2024.100827
DO - 10.1016/j.lana.2024.100827
M3 - Comment/debate
AN - SCOPUS:85196539578
SN - 2667-193X
VL - 36
JO - The Lancet Regional Health - Americas
JF - The Lancet Regional Health - Americas
M1 - 100827
ER -